Robinhood Markets, Inc. Other Income (Expense) decreased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 100.0%, from $1.00M to $0.00. Over 4 years (FY 2021 to FY 2025), Other Income (Expense) shows an upward trend with a 58.0% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$710.00K | $1.96M | $0.00 | $0.00 | -$2.00M | $0.00 | -$14.00M | $0.00 | $2.00M | -$2.00M | $3.00M | $4.00M | $2.00M | $2.00M | $2.00M | $1.00M | $3.00M | -$1.00M | $11.00M | $0.00 |
| QoQ Change | — | +375.4% | -100.0% | — | — | +100.0% | — | +100.0% | — | -200.0% | +250.0% | +33.3% | -50.0% | +0.0% | +0.0% | -50.0% | +200.0% | -133.3% | >999% | -100.0% |
| YoY Change | — | — | — | — | -181.7% | -100.0% | — | — | +200.0% | — | +121.4% | — | +0.0% | +200.0% | -33.3% | -75.0% | +50.0% | -150.0% | +450.0% | -100.0% |
| Segment | Q3 '22 | Q1 '23 |
|---|---|---|
| Fully Paid Securities Lending | $4.00M | $8.00M |
| Total | $0.00 | $0.00 |
| Segment | FY'25 |
|---|---|
| Securities lending, net | $190.00M |
| Total | $14.00M |
All segment values are derived from annual filings.